Published in J Gastroenterol Hepatol on June 01, 2003
Extensive intestinal ischaemic necrosis in Wegener's granulomatosis. Gut (2006) 0.94
New insights into gastrointestinal and hepatic granulomatous disorders. Nat Rev Gastroenterol Hepatol (2011) 0.87
Wegener's granulomatosis with massive gastrointestinal hemorrhage due to jejunal and colonic involvement: report of a case. Surg Today (2008) 0.81
Wegener's granulomatosis mimicking inflammatory bowel disease and presenting with chronic enteritis. Int Med Case Rep J (2013) 0.78
Upper Gastrointestinal Bleeding as the First Manifestation of Wegener's Granulomatosis. Middle East J Dig Dis (2016) 0.75
Diffuse Large B Cell Lymphoma Mimicking Granulomatosis with Polyangiitis. Case Rep Rheumatol (2016) 0.75
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2008) 4.72
Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol (2003) 4.15
The ultrafiltration coefficient of a dialyser (KUF) is not a fixed value, and it follows a parabolic function: the new concept of KUF max. Nephrol Dial Transplant (2010) 2.75
Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol (2004) 2.66
Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int (2010) 2.10
Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.93
Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status. Am J Kidney Dis (2012) 1.91
Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.75
ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry. Am J Kidney Dis (2002) 1.69
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol (2006) 1.67
Home haemodialysis in Australia - is the wheel turning full circle? Med J Aust (2010) 1.67
Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice. Nephrol Dial Transplant (2010) 1.62
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis (2004) 1.62
A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection. Transplantation (2009) 1.49
Prospective psychosocial monitoring of living kidney donors using the SF-36 health survey. Transplantation (2003) 1.44
Anorexia nervosa and senna misuse: nephrocalcinosis, digital clubbing and hypertrophic osteoarthropathy. Med J Aust (2008) 1.43
Native arteriovenous fistula blood flow and resistance during hemodialysis. Am J Kidney Dis (2003) 1.43
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant (2007) 1.42
Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results. Nephrology (Carlton) (2004) 1.38
Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis (2011) 1.37
Generation of induced pluripotent stem cells from human kidney mesangial cells. J Am Soc Nephrol (2011) 1.36
Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis (2003) 1.24
Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients. Kidney Int (2002) 1.21
Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD. Am J Kidney Dis (2007) 1.20
Renal dialysis abatement: lessons from a social study. Palliat Med (2005) 1.17
The directed differentiation of human iPS cells into kidney podocytes. PLoS One (2012) 1.15
Effect of a vascular access nurse coordinator to reduce central venous catheter use in incident hemodialysis patients: a quality improvement report. Am J Kidney Dis (2008) 1.15
Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2012) 1.15
Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr Nephrol (2011) 1.12
Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study. Nephrol Dial Transplant (2008) 1.10
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial. Nephrol Dial Transplant (2010) 1.10
Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Kidney Int (2011) 1.09
Increasing home based dialysis therapies to tackle dialysis burden around the world: a position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis. Nephrology (Carlton) (2011) 1.06
Arterial function after successful renal transplantation. Kidney Int (2004) 1.04
Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis (2004) 1.03
Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Clin J Am Soc Nephrol (2008) 1.02
How Australian nephrologists view home dialysis: results of a national survey. Nephrology (Carlton) (2011) 1.02
Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial. Nephrology (Carlton) (2011) 1.00
Does monthly native arteriovenous fistula blood-flow surveillance detect significant stenosis--a randomized controlled trial. Nephrol Dial Transplant (2006) 1.00
Longitudinal body composition changes due to dialysis. Clin J Am Soc Nephrol (2011) 0.94
Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients? Nephrology (Carlton) (2008) 0.93
Thalassemia bone disease: a 19-year longitudinal analysis. J Bone Miner Res (2014) 0.93
Vascular calcification and arterial stiffness in chronic kidney disease: implications and management. Nephrology (Carlton) (2007) 0.92
Prospective psychosocial monitoring of living kidney donors using the Short Form-36 health survey: results at 12 months. Transplantation (2004) 0.92
Review of dialysate calcium concentration in hemodialysis. Hemodial Int (2006) 0.91
Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial. Am J Kidney Dis (2010) 0.91
Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis. Am J Nephrol (2011) 0.89
Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients. Hemodial Int (2008) 0.89
Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients. Clin J Am Soc Nephrol (2008) 0.87
Vascular access practice patterns in the New Zealand hemodialysis population. Am J Kidney Dis (2004) 0.87
Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. Am J Kidney Dis (2013) 0.86
25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol (2012) 0.86
Seasonal modifications in blood pressure are mainly related to interdialytic body weight gain in dialysis patients. Kidney Int (2004) 0.83
Epidemiology of vascular access in the Australian hemodialysis population. Kidney Int (2003) 0.83
The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes. Nephrology (Carlton) (2008) 0.83
Home hemodialysis in Australia and New Zealand: how and why it has been successful. Semin Dial (2011) 0.82
Effect of exercise on albuminuria in people with diabetes. Nephrology (Carlton) (2011) 0.81
Outcomes of extended-hours hemodialysis performed predominantly at home. Am J Kidney Dis (2012) 0.81
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial. Nephrol Dial Transplant (2009) 0.81
A rational guide to reducing fracture risk in dialysis patients. Semin Dial (2010) 0.81
Thrice-weekly nocturnal hemodialysis: the overlooked alternative to improve patient outcomes. Nephrol Dial Transplant (2013) 0.81
Prospective quality-of-life monitoring of simultaneous pancreas and kidney transplant recipients using the 36-item short form health survey. Am J Kidney Dis (2010) 0.81
Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross-sectional study of prevalent Australian haemodialysis patients. Nephrology (Carlton) (2009) 0.80
Cardiovascular risk in dialysis patients: a comparison of risk factors and cardioprotective therapy between 1996 and 2001. Nephrology (Carlton) (2003) 0.80
Water quality in conventional and home haemodialysis. Nat Rev Nephrol (2012) 0.79
Body composition in home haemodialysis versus conventional haemodialysis: a cross-sectional, matched, comparative study. Nephrol Dial Transplant (2009) 0.79
Using vertebral bone densitometry to determine aortic calcification in patients with chronic kidney disease. Nephrology (Carlton) (2010) 0.78
Lateral lumbar X-ray assessment of abdominal aortic calcification in Australian haemodialysis patients. Nephrology (Carlton) (2011) 0.78
Measurement of vascular calcification using CT fistulograms. Nephrol Dial Transplant (2006) 0.78
Anti-CD20 antibody treatment in refractory Class IV lupus nephritis. Nephrol Dial Transplant (2006) 0.78
Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency. Nephrology (Carlton) (2005) 0.77
Increasing home dialysis knowledge through a web-based e-learning program. Nephrology (Carlton) (2014) 0.77
Dialysis: Nocturnal hemodialysis--should we still provide this therapy? Nat Rev Nephrol (2011) 0.76
Blood pressure and blood volume: acute and chronic considerations in hemodialysis. Semin Dial (2012) 0.76
Comparison between different dialysate calcium concentrations in nocturnal hemodialysis. Hemodial Int (2007) 0.76
Vitamin D therapy in chronic kidney disease: back to the future? Clin Nephrol (2015) 0.76
Debate: Should dialysis at home be mandatory for all suitable ESRD patients?: home-based dialysis therapies are the second choice after transplantation. Semin Dial (2014) 0.76
A case of hypophosphatemic osteomalacia secondary to deferasirox therapy. J Bone Miner Res (2012) 0.75
Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial. Am J Kidney Dis (2008) 0.75
Historical controlled trial of OKT3 versus basiliximab induction therapy in simultaneous pancreas-renal transplantation. Nephrology (Carlton) (2003) 0.75
What have we learned from clinical trials on prevention? Kidney Int Suppl (2005) 0.75
Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination. Kidney Int (2012) 0.75
Renal allograft re-use and herpetic re-infection. Nephrology (Carlton) (2015) 0.75
Erythropoietic agents, iron and hemoglobin--What happens beyond the trial setting: observational data from the ANZDATA registry. Hemodial Int (2004) 0.75
Preeclampsia and Long-term Renal Function in Women Who Underwent Kidney Transplantation. Obstet Gynecol (2017) 0.75
Home Hemodialysis: What Is Old Is New Again. Contrib Nephrol (2017) 0.75
Determinants of native arteriovenous fistula blood flow. Nephrology (Carlton) (2004) 0.75
Increased incidence of benign breast disease in female renal transplant patients receiving cyclosporin. ANZ J Surg (2002) 0.75